ID   HF3177
AC   CVCL_C8PS
DR   Wikidata; Q123031662
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 185 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=32064048; DOI=10.18632/oncotarget.27457; PMCID=PMC6996910;
RA   Ye, Ling F.
RA   Reznik, Eduard
RA   Korn, Joshua M.
RA   Lin, Fallon
RA   Yang, Gui-Zhi
RA   Malesky, Kimberly
RA   Gao, Hui
RA   Loo, Alice
RA   Pagliarini, Raymond
RA   Mikkelsen, Tom
RA   Lo, Donald C.
RA   deCarvalho, Ana C.
RA   Stockwell, Brent Roark
RT   "Patient-derived glioblastoma cultures as a tool for small-molecule
RT   drug discovery.";
RL   Oncotarget 11:443-451(2020).
//